About this trial
Phantom limb pain (PLP) is a significant and pervasive issue among upper limb amputees, severely impacting their quality of life. The literature delineating prevalence of upper versus lower limb amputations is limited, but the prevalence of total amputations in the United States is estimated to reach 3 million individuals by 2050, with approximately 185,000 new cases annually. PLP affects 60-68% of these patients, leading to heightened levels of anxiety, depression, and reduced overall well-being.
Eligibility criteria
Qualifiers
History of major limb amputation
Age > 18 years old
Presence of phantom limb pain or negative phantom sensation(s)
Disqualifiers
Active mental illness, neurological disease, or cognitive impairment that would interfere with survey completion
Those without phantom limb pain or negative phantom limb sensations
Non-English speaking
Trial design
Treatments tested in this trial
- virtual reality therapy
- matched control group